P2Y12 INHIBITOR

Clinical trials for P2Y12 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new P2Y12 INHIBITOR trials appear

Sign up with your email to follow new studies for P2Y12 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Heart treatment trial aims to reduce bleeding risk in elderly patients

Disease control Recruiting now

This international study is testing whether using just one blood-thinning medication is as safe and effective as using two after a specific type of heart artery procedure. It focuses on patients aged 75 and older or those at high risk for bleeding. The goal is to find the best ba…

Matched conditions: P2Y12 INHIBITOR

Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

P2Y12 INHIBITOR

Get alerted when new P2Y12 INHIBITOR trials appear

Heart treatment trial aims to reduce bleeding risk in elderly patients